drug protocol number

1378-0020

drug sponsor

Boehringer Ingelheim

drug study

BI 690517 , empagliflozin

drug trial site

King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase